ARCHIVES

NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments

This article is from The Cancer Letter archive.

Vol. 11 No. 12 | March 22, 1985

Download PDF Visit The Full Archive

Related Articles

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011

NCAB Wants NCI To Avoid Setting Guidelines Regarding Health Policy

March 4, 1994

Waxman To Speak At AACI Meeting

January 12, 1979

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

GAO Criticizes Distribution Of Comprehensive Cancer Centers, Cite Needs for “Focal Point” Clarification

March 26, 1976

Survival Of Control Programs After NCI Money Runs Out Developing Into A Worrisome Issue

June 1, 1975